T40.724

Clinical Causes: Use of synthetic cannabinoids, also known as 'spice' or 'K2', which are synthetic chemicals sprayed onto plant material and smoked or vaporized. Accidental ingestion of or exposure to unknown or mislabeled synthetic compounds sold illicitly. Intentional misuse by individuals seeking psychoactive effects without understanding the potential harms. Distribution of illegal synthetic drugs that mimic the effects of natural cannabis but contain different chemical profiles.

Key Symptoms: Altered mental state, including confusion, agitation, or hallucinations Nausea and vomiting Elevated heart rate (tachycardia) High blood pressure (hypertension) Rapid breathing (tachypnea) Chest pain Seizures Anxiety and paranoia Dizziness or fainting Loss of consciousness Potential psychotic episodes

Diagnosis Path: Diagnosis typically involves a combination of clinical assessment and patient history. Because synthetic cannabinoids are constantly evolving, standard drug tests may not detect all substances involved. Healthcare professionals may rely on symptom presentation and exclude other causes through laboratory tests, including blood and urine analyses, although detection can be challenging. In some cases, specialized testing is required to identify specific synthetic compounds, but this isn't always available.

Treatment Protocols: Treatment focuses on managing symptoms and ensuring patient safety. Supportive care may include continuous monitoring of vital signs, administration of activated charcoal if ingestion is recent, and medications to control agitation, seizures, or other adverse effects. Hospitalization might be necessary for severe cases. Importantly, there are no specific antidotes for synthetic cannabinoid poisoning; thus, intervention is primarily supportive and symptomatic. Mental health support and counseling may be recommended once stabilized to address potential psychological impacts.